rhASA
HGT-MLD-071
Phase 2 small_molecule active
Quick answer
rhASA for Late Metachromatic Leukodystrophy (MLD) is a Phase 2 program (small_molecule) at Shire with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shire
- Indication
- Late Metachromatic Leukodystrophy (MLD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active